Orgenesis (ORGS) Short Interest Ratio & Short Volume $1.21 +0.11 (+10.00%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSustainabilityTrends Orgenesis Short Interest DataOrgenesis (ORGS) has a short interest of 33,800 shares, representing 0.29% of the float (the number of shares available for trading by the public). This marks a -39.96% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.8, indicating that it would take 0.8 days of the average trading volume of 10,633 shares to cover all short positions.Current Short Interest33,800 sharesPrevious Short Interest56,300 sharesChange Vs. Previous Month-39.96%Dollar Volume Sold Short$98,020.00Short Interest Ratio0.8 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares4,799,000 sharesFloat Size11,850,000 sharesShort Percent of Float0.29%Today's Trading Volume4,744 sharesAverage Trading Volume10,633 sharesToday's Volume Vs. Average45% Short Selling Orgenesis? Sign up to receive the latest short interest report for Orgenesis and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartORGS Short Interest Over TimeORGS Days to Cover Over TimeORGS Percentage of Float Shorted Over Time Ad Darwin2024 Election Year Stocks: Uncover Hidden Gems!In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss.Secure your copy now by clicking this link. Orgenesis Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/202433,800 shares $98,020.00 -40.0%0.3%0.8 $2.90 9/30/202456,300 shares $251,098.00 -85.1%1.3%2.5 $4.46 9/15/2024377,400 shares $229,421.46 -6.8%N/A2 $0.61 8/31/2024405,100 shares $271,376.49 -9.1%N/A2 $0.67 8/15/2024445,500 shares $414,315.00 +23.8%N/A2.3 $0.93 7/31/2024359,900 shares $284,321.00 +48.4%N/A2.5 $0.79 Get the Latest News and Ratings for ORGS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Orgenesis and its competitors with MarketBeat's FREE daily newsletter. 7/15/2024242,600 shares $169,820.00 -10.9%N/A2.7 $0.70 6/30/2024272,400 shares $163,440.00 +39.8%N/A1.5 $0.60 6/15/2024194,900 shares $113,003.02 -5.1%N/A1 $0.58 5/31/2024205,400 shares $105,760.46 -17.6%N/A1.3 $0.51 5/15/2024249,300 shares $141,029.01 -13.5%N/A1.4 $0.57 4/30/2024288,100 shares $145,605.74 -28.4%N/A1.3 $0.51 4/15/2024402,500 shares $201,129.25 +34.3%N/A1.7 $0.50 3/31/2024299,700 shares $246,353.40 -7.0%N/A1.9 $0.82 3/15/2024322,200 shares $254,280.24 +42.8%N/A2.2 $0.79 2/29/2024225,700 shares $144,493.14 -7.4%N/A1.5 $0.64 2/15/2024243,800 shares $117,024.00 +61.6%N/A1.7 $0.48 1/31/2024150,900 shares $47,382.60 +25.2%N/A1.6 $0.31 1/15/2024120,500 shares $36,029.50 -36.4%N/A1.3 $0.30 12/31/2023189,500 shares $94,882.65 +47.0%N/A2.4 $0.50 12/15/2023128,900 shares $63,844.17 -39.3%N/A1.8 $0.50 11/30/2023212,300 shares $97,997.68 -12.2%N/A3.4 $0.46 11/15/2023241,900 shares $133,045.00 +21.5%N/A2.4 $0.55 10/31/2023199,100 shares $135,407.91 -18.7%0.8%1.8 $0.68 10/15/2023244,800 shares $206,537.76 +18.4%1.0%2.5 $0.84 9/30/2023206,800 shares $128,216.00 -29.0%0.9%2.1 $0.62 9/15/2023291,400 shares $201,066.00 +45.4%1.2%3.1 $0.69 8/31/2023200,400 shares $102,023.64 +2.4%0.9%2.3 $0.51 8/15/2023195,700 shares $192,568.80 +8.6%N/A4.4 $0.98 7/31/2023180,200 shares $196,418.00 -13.3%N/A6.5 $1.09 7/15/2023207,900 shares $270,270.00 -7.2%N/A7.1 $1.30 6/30/2023224,100 shares $311,499.00 +13.6%N/A7.4 $1.39 6/15/2023197,200 shares $256,360.00 -1.0%N/A5.5 $1.30 5/31/2023199,100 shares $236,929.00 +6.9%N/A4.4 $1.19 5/15/2023186,300 shares $199,359.63 -11.5%N/A2.4 $1.07 4/30/2023210,600 shares $231,660.00 -43.4%N/A2.8 $1.10 4/15/2023372,100 shares $427,915.00 -17.2%N/A5 $1.15 3/31/2023449,600 shares $530,528.00 +47.5%N/A5.9 $1.18 3/15/2023304,800 shares $377,952.00 -19.1%1.3%4.3 $1.24 2/28/2023376,800 shares $542,592.00 +91.0%1.6%6.3 $1.44Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW 2/15/2023197,300 shares $420,249.00 +0.4%1.0%3.4 $2.13 1/31/2023196,600 shares $471,840.00 -12.7%1.0%1.8 $2.40 1/15/2023225,100 shares $535,738.00 +2.4%1.1%2 $2.38 12/30/2022219,800 shares $428,610.00 +4.9%1.0%2 $1.95 12/15/2022209,500 shares $427,380.00 -5.1%1.0%1.9 $2.04 11/30/2022220,800 shares $441,600.00 -25.9%1.0%2.1 $2.00 11/15/2022298,000 shares $643,680.00 +53.8%1.4%2.9 $2.16 10/31/2022193,800 shares $259,692.00 +2.1%0.9%1.8 $1.34 10/15/2022189,900 shares $241,173.00 -4.7%0.8%5.1 $1.27 9/30/2022199,300 shares $283,006.00 +28.5%0.9%5.8 $1.42 9/15/2022155,100 shares $285,384.00 -9.9%0.7%4.8 $1.84 8/31/2022172,200 shares $334,068.00 +13.1%0.8%5.1 $1.94 8/15/2022152,300 shares $284,801.00 -10.4%0.7%4.2 $1.87 7/31/2022169,900 shares $316,014.00 -17.0%0.8%4 $1.86 7/15/2022204,600 shares $460,350.00 -8.7%0.9%5.6 $2.25 6/30/2022224,100 shares $542,322.00 +37.7%1.0%6.2 $2.42 6/15/2022162,700 shares $323,773.00 -24.5%0.7%3.4 $1.99 5/31/2022215,400 shares $553,578.00 +52.4%1.0%4.8 $2.57 5/15/2022141,300 shares $402,705.00 -3.2%0.6%3.2 $2.85 4/30/2022145,900 shares $437,700.00 -27.6%0.7%4.8 $3.00 4/15/2022201,500 shares $687,115.00 +6.1%0.9%5.4 $3.41 3/31/2022190,000 shares $659,300.00 +2.9%0.9%4 $3.47 3/15/2022184,700 shares $528,242.00 -19.3%0.9%3.6 $2.86 2/28/2022229,000 shares $721,350.00 -11.9%1.1%3.7 $3.15 2/15/2022259,900 shares $813,487.00 +4.9%1.3%3.7 $3.13 1/31/2022247,700 shares $775,301.00 +12.8%1.2%3 $3.13 1/15/2022219,600 shares $507,276.00 -6.7%1.0%2.5 $2.31 12/31/2021235,400 shares $677,952.00 +0.3%1.1%2.8 $2.88 12/15/2021234,600 shares $694,416.00 +9.4%1.1%3.4 $2.96 11/30/2021214,500 shares $664,950.00 -14.8%1.0%3.4 $3.10 11/15/2021251,700 shares $1.02 million -1.1%1.2%4.4 $4.06 10/29/2021254,400 shares $1.22 million -17.3%1.2%4.7 $4.81 10/15/2021307,500 shares $1.46 million -25.7%1.4%6.3 $4.76 9/30/2021413,600 shares $2.05 million -27.9%1.9%8 $4.95 9/15/2021573,800 shares $2.85 million -3.7%2.7%5.9 $4.96 8/31/2021595,900 shares $3.19 million +3.0%2.8%5.1 $5.35 8/13/2021578,500 shares $2.99 million -20.5%2.7%4.2 $5.16 7/30/2021727,700 shares $3.57 million +8.9%3.4%4 $4.90 7/15/2021668,300 shares $3.21 million -2.2%3.1%1.4 $4.80 6/30/2021683,000 shares $3.46 million -62.7%3.2%1.5 $5.07 6/15/20211,830,000 shares $9.50 million No Change8.5%4.1 $5.19 5/28/20211,830,000 shares $8.84 million +16.6%8.5%4.1 $4.83 5/14/20211,570,000 shares $6.92 million +36.5%N/A3.5 $4.41 4/30/20211,150,000 shares $5.42 million +31.0%N/A2.6 $4.71 4/15/2021878,000 shares $4.64 million +16.6%N/A6 $5.28 3/31/2021753,000 shares $4.18 million +37.8%N/A4.1 $5.55 3/15/2021546,600 shares $4.42 million +62.6%N/A3.1 $8.08 2/26/2021336,100 shares $2.32 million +6.9%N/A2.2 $6.89 2/12/2021314,500 shares $2.09 million -3.5%N/A2.4 $6.66 1/29/2021326,000 shares $2.04 million -2.1%N/A2.9 $6.25Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW 1/15/2021332,900 shares $1.70 million -2.7%N/A3.3 $5.12 12/31/2020342,200 shares $1.56 million +2.9%N/A6.6 $4.55 12/15/2020332,600 shares $1.57 million -13.4%N/A7.2 $4.72 11/30/2020384,100 shares $1.90 million +0.6%N/A8.8 $4.95 11/15/2020382,000 shares $1.86 million -0.2%N/A8.9 $4.86 10/30/2020382,700 shares $1.78 million -8.9%N/A8.9 $4.66 10/15/2020420,200 shares $2.21 million -0.9%N/A8.8 $5.26 ORGS Short Interest - Frequently Asked Questions What is Orgenesis' current short interest? Short interest is the volume of Orgenesis shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 33,800 shares of ORGS short. 0.29% of Orgenesis' shares are currently sold short. Learn More on Orgenesis' current short interest. What is a good short interest ratio for Orgenesis? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ORGS shares currently have a short interest ratio of 1.0. Learn More on Orgenesis's short interest ratio. What is a good short interest percentage for Orgenesis? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.29% of Orgenesis' floating shares are currently sold short. Is Orgenesis' short interest increasing or decreasing? Orgenesis saw a decrease in short interest in the month of October. As of October 15th, there was short interest totaling 33,800 shares, a decrease of 40.0% from the previous total of 56,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Orgenesis' float size? Orgenesis currently has issued a total of 4,799,000 shares. Some of Orgenesis' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Orgenesis currently has a public float of 11,850,000 shares. How does Orgenesis' short interest compare to its competitors? 0.29% of Orgenesis' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Orgenesis: MIRA Pharmaceuticals, Inc. (12.65%), GlycoMimetics, Inc. (8.75%), Spruce Biosciences, Inc. (0.56%), Cyclo Therapeutics, Inc. (0.69%), Unity Biotechnology, Inc. (1.97%), MEI Pharma, Inc. (1.23%), ProPhase Labs, Inc. (0.65%), Enlivex Therapeutics Ltd. (0.75%), Cognition Therapeutics, Inc. (2.41%), Bullfrog AI Holdings, Inc. (4.76%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Orgenesis stock? Short selling ORGS is an investing strategy that aims to generate trading profit from Orgenesis as its price is falling. ORGS shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Orgenesis? A short squeeze for Orgenesis occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ORGS, which in turn drives the price of the stock up even further. How often is Orgenesis' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ORGS, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies MIRA Pharmaceuticals Short Interest GlycoMimetics Short Interest Spruce Biosciences Short Interest Cyclo Therapeutics Short Interest Unity Biotechnology Short Interest MEI Pharma Short Interest ProPhase Labs Short Interest Enlivex Therapeutics Short Interest Cognition Therapeutics Short Interest Bullfrog AI Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ORGS) was last updated on 11/24/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored#1 Crypto of 2024Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orgenesis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orgenesis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ORGS Stock Alerts